PROJECTS
Completed projects
Reference |
Home |
Public Organization |
Title |
| H2020-NMP-2014-646142 | 2018 | Comisión Europea | A Pilot Plant for the Production of Polymer based Nanopharmaceuticals in Compliance with GMP. |
| H2020-2014-P-642028 | 2018 | European Commission | Design and Development of advanced NAnomedicines to overcome Biological Barriers and to treat severe diseases. |
| IDI-20170221 | 2017 | CDTI | Design of a platform for the pharmacological screening of SIRNAS and its validation in the treatment of Age-Related Macular Degeneration (AMD). Typology: Predictive software, Big Data, algorithms, modelling, Drug Discovery. |
| IDI-20160210 | 2017 | CDTI | Progress in the development of the SYL1001 product for the treatment of dry eye syndrome: Phase III clinical trial and process optimisation. Type: Phase III clinical trial. |
| RTC-2016-4884-1 | 2017 | State Investigation Agency | Innovative solutions for the treatment of dry eye combined with eye pain. |
| RTC-2014-2375-1 | 2017 | State Investigation Agency | New approaches to the diagnosis, treatment and regeneration of ocular surface pathology-SURFeye |
| RTC-2014-2038-1 | 2015 | State Investigation Agency | New Treatments for Degenerative Retinal Diseases (TERET) |
|
IPT-2012-0438-010000 |
2015 |
State Investigation Agency |
Innovative solutions for the treatment and diagnosis of dry eye syndrome |
|
IDI-20140748 |
2014 |
CDTI |
Phase IIb clinical trial and pharmacokinetic study of bamosiran for the treatment of glaucoma. |
|
IDI-20130006 |
2012 |
CDTI |
Phase II glaucoma clinical trial |
|
IPT-2012-0438-010000* |
2012 |
Ministry of Economy and Competitiveness |
Innovative solutions for the treatment and diagnosis of dry eye syndrome |
|
CEN-20101023* |
2010 |
CDTI |
Innovative solutions to accelerate the identification and development of new drugs for the treatment of nervous system pathologies. |
|
IDI-20101188 |
2010 |
CDTI |
Progress in the development of New Ophthalmic Therapies |
|
PIE/23/2010 |
2010 |
Community of Madrid |
The search for an oral treatment for inflammatory bowel disease |
|
PIE/25/2010 |
2010 |
Community of Madrid |
Symptomatic improvement of dry eye using new therapies. |
|
CEN-20091021* |
2009 |
CDTI |
CEYEC-Customatized eye care. Personalised and minimally invasive ophthalmology |
|
IDI-20090417 |
2009 |
CDTI |
Research and development of a compound for the treatment of glaucoma based on RNAi technology. |
|
CAM 6/2009 |
2009 |
Community of Madrid |
Therapeutic use of RNAi for the treatment of Central Nervous System diseases |
|
PIE/214/2009 |
2009 |
Community of Madrid |
RNAi , New Therapy for Ocular Pain – Dry Eye. |
|
PIE/90/2008 |
2008 |
Community of Madrid |
Treatment of disease inflammatory bowel disease using RNA interference technology |
|
CAM 32/2007 |
2007 |
Community of Madrid |
Therapeutic applications of RNA interference |
|
CEN-20060011 |
2006 |
CDTI |
Nanotechnology-based drug delivery systems |
Español